Related Experiment Video

Updated: Jun 15, 2026

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

Economics of influenza vaccine administration timing for children

Bruce Y Lee1, Julie H Y Tai, Rachel R Bailey

  • 1Public Health Computation and Operations Research (PHICOR) Group, University of Pittsburgh, Pittsburgh, PA 15213, USA. byl1@pitt.edu

The American Journal of Managed Care
|March 9, 2010
PubMed

Insights

Investing in early childhood influenza vaccination by October offers significant economic and health benefits. Early vaccination can save millions and improve quality-adjusted life-years (QALYs), making it a cost-effective public health strategy.

Area of Science:

  • Public Health
  • Health Economics
  • Epidemiology

Background:

  • Influenza vaccination is crucial for child health.
  • Optimal timing for childhood influenza vaccination is a key public health consideration.
  • Current vaccination schedules may not maximize economic and health benefits.

Purpose of the Study:

  • To determine the optimal annual investment for early childhood influenza vaccination.
  • To establish the ideal timeframe for administering influenza vaccines to children each season.

Main Methods:

  • Utilized Monte Carlo decision analytic computer simulation models.
  • Quantified the economic value of earlier vaccination versus delayed vaccination.
  • Evaluated the cost-effectiveness of monthly vaccination decisions.

Main Results:

  • Vaccinating children by the end of October could save society $6.4-$9.2 million and 653-926 QALYs annually.
  • Third-party payers could save $4.1-$6.1 million and 647-942 QALYs.
  • Continuing vaccination through December is recommended; trivalent inactivated vaccines are more cost-effective than live attenuated vaccines.

Conclusions:

  • Policymakers can invest $6-$9 million annually for September/October vaccination with no net cost.
  • Early influenza vaccination in children is economically advantageous.
  • Optimizing vaccination timing enhances public health outcomes and resource allocation.
Abstract

More Related Videos

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B05:38

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

Published on: January 30, 2017

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.